Celldex Therapeutics, Inc. (CLDX) vs Disc Medicine, Inc. (IRON)

Celldex Therapeutics, Inc. and Disc Medicine, Inc. are both Biotechnology companies. Celldex Therapeutics, Inc. and Disc Medicine, Inc. are of similar size ($2.6B and $2.5B). Disc Medicine, Inc. has the higher net margin (0.00% vs −33,883.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Disc Medicine, Inc. leads on 9 and Celldex Therapeutics, Inc. on 4.

Valuation

Metric CLDX IRON Biotechnology median
P/E n/m n/m 7.88
P/S 2,729.23 n/m 11.47
P/B 3.39 3.93 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1,923.07 n/m 10.73
Earnings yield (13.99%) (10.05%) (28.84%)
Free cash flow yield (10.00%) (7.84%) (23.03%)

Profitability

Metric CLDX IRON Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (36,733.82%) 0.00% 0.00%
Net margin (33,883.77%) 0.00% 0.00%
Free cash flow margin (27,294.81%) 0.00% 0.00%
Return on equity (43.88%) (39.08%) (57.72%)
Return on assets (40.76%) (35.12%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLDX IRON Biotechnology median
Revenue growth (TTM) (88.27%) — 5.64%
EPS growth (last fiscal year) (59.18%) (51.77%) —
Revenue growth, 5-year CAGR (26.93%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLDX IRON Biotechnology median
Debt to equity 0.00 0.09 0.00
Current ratio 11.82 24.14 4.73
Net debt to EBITDA 1.78 3.12 0.96

Dividend

Metric CLDX IRON Biotechnology median
Dividend yield 2.16% — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CLDX IRON Biotechnology median
Market cap 2.49b 2.55b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack